Status:
COMPLETED
Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Termination of Pregnancy
Covid19
Eligibility:
FEMALE
16-45 years
Brief Summary
To see the impact the COVID-19 pandemic has had on early spontaneous abortions and early termination of pregnancy in the first trimester
Detailed Description
To date, the research has focused on the complications of SARS-CoV-2 in pregnant women. There is no research in the literature that has compared the rates and behavior of miscarriage during the time o...
Eligibility Criteria
Inclusion
- All women attending for early missed abortion or termination of pregnancy receiving treatment between March 11th - November 30th during the years 2017-2020 Gestational age until 12 weeks 6 days (1st trimester only)
Exclusion
- Incomplete and complete abortions
- Gestational age \>13 weeks
Key Trial Info
Start Date :
January 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 9 2022
Estimated Enrollment :
411 Patients enrolled
Trial Details
Trial ID
NCT04910958
Start Date
January 6 2021
End Date
August 9 2022
Last Update
December 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel